Davion Healthcare Plc (DAVI)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	n/a
Revenue (ttm)	n/a
Net Income	-1.37M
EPS	-0.05
Shares Out	25.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DAVI

Davion Healthcare Plc is an Irish Public Limited Company focused exclusively on the development and commercialization of non-invasive home diagnostic tests for the early detection of health anomalies, including cancers. Our products are classified as Class I medical devices and are fully registered with regulatory authorities in the United States (FDA), the European Union (CE mark), and the United Kingdom (UKCA). Our flagship product, BreastCheck, is a non-invasive home test designed to detect temperature anomalies in breast tissue, which may b...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2022
• Country: Ireland
• Stock Exchange: NASDAQ
• Ticker Symbol: DAVI
• Website: https://www.davionhealthcare.com/

Financial Performance

Financial numbers in EUR

Data Source: SEC filings Last updated: Aug 6, 2026

The data for this page was gathered manually by the Stock Analysis team, from official company filings available on SEC.gov.

Data Sources Report a data error